| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9886 |
| Human Intestinal Absorption | HIA+ | 0.9738 |
| Caco-2 Permeability | Caco2+ | 0.7965 |
| P-glycoprotein Substrate | Substrate | 0.6637 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6501 |
| Inhibitor | 0.7613 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5286 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5687 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7739 |
| CYP450 2D6 Substrate | Substrate | 0.7480 |
| CYP450 3A4 Substrate | Substrate | 0.5224 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8040 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9195 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.9381 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8436 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6702 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6487 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9819 |
| Inhibitor | 0.8180 |
| AMES Toxicity | Non AMES toxic | 0.7784 |
| Carcinogens | Non-carcinogens | 0.9034 |
| Fish Toxicity | High FHMT | 0.8027 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7034 |
| Honey Bee Toxicity | Low HBT | 0.6673 |
| Biodegradation | Not ready biodegradable | 0.9968 |
| Acute Oral Toxicity | II | 0.7388 |
| Carcinogenicity (Three-class) | Non-required | 0.6246 |